Publications
Publications
- June 1996 (Revised February 1998)
- HBS Case Collection
Repositioning Ranbaxy
Abstract
A leading Indian pharmaceutical company reacts to changes in its industry by trying to reposition along several dimensions from developing markets to developed ones, from bulk drugs toward pharmaceuticals in dosage forms, and from reverse-engineering products developed by others toward original research.
Keywords
Organizational Change and Adaptation; Expansion; Industry Structures; Pharmaceutical Industry; India
Citation
Ghemawat, Pankaj, and Kazbi Kothavala. "Repositioning Ranbaxy." Harvard Business School Case 796-181, June 1996. (Revised February 1998.)